2 BREATHE Chat program

El Camino Health, Conversa Health launch 2 BREATHE Chat program

Said program enables patients with COPD, asthma and other respiratory illnesses to be monitored remotely by their care team.
Propeller Health app - MyPharmacy

Propeller Health updates its app to add access to pharmacy services from CVS, Walmart,...

With the expansion of the My Pharmacy feature, patients can use Propeller to refill prescriptions with 5 of the 7 largest pharmaceutical providers in the U.S.
Propeller Health smart inhaler

Propeller Health, Orion to bring new digital medicines to people with asthma and COPD

Under the deal, Orion's existing line of Easyhaler products will connect to Propeller's digital medicine platform via a small, custom-built sensor.
Propeller Health

Propeller Health, Express Scripts team-up to improve health for people with asthma and COPD

Propeller's FDA-cleared digital solution will be provided to Express Scripts members using inhaler sensors and a mobile app to manage asthma or COPD.
Propeller Health API

Propeller Health unveils its very first API

Called Air by Propeller, it provides local asthma conditions to anyone in the US who would like to share this insight with their audiences.
Propeller Health

Propeller Health, GSK expand their collaboration to improve management of asthma and COPD

The two companies will undertake commercial activities using the Propeller clip-on sensor and software platform for use with GSK's ELLIPTA Inhaler.
Wing sensor

Sparo Labs’ sensor for tracking lung function Wing now available for $129

Using Wing, users are able to detect early declines in lung function and take action to prevent asthma attacks, even before any symptoms were noticed.
Propeller Health

Study: Digital health tech can improve asthma outcomes

The study demonstrated effectiveness of the Propeller Health Asthma Management Platform to better manage chronic respiratory disease.
3M Intelligent Control Inhaler

3M joins the connected inhaler market with 3M Intelligent Control Inhaler

The fully-integrated device delivers accurate doses to asthma and COPD patients, whilst providing on-screen instructions and feedback to the patient.

ResApp raises $12.5M for its mobile-enabled respiratory disease tool

The funds will be used to expedite an FDA approval for the adult diagnostic test, expand into in-clinic use, and enter European and Asian markets.